Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Number of holders
-
214
-
Total 13F shares, excl. options
-
122,545,305
-
Shares change
-
-1,202,428
-
Total reported value, excl. options
-
$3,667,866,974
-
Value change
-
-$30,050,711
-
Put/Call ratio
-
24.03%
-
Number of buys
-
117
-
Number of sells
-
-93
-
Price
-
$29.94
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q1 2020
267 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q1 2020.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122,545,305 shares
of 334,352,960 outstanding shares and own 36.65% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11,670,057 shares), VANGUARD GROUP INC (11,129,211 shares), BlackRock Inc. (9,898,874 shares), Avoro Capital Advisors LLC (9,010,413 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,780,431 shares), FARALLON CAPITAL MANAGEMENT LLC (5,750,000 shares), ORBIMED ADVISORS LLC (5,548,326 shares), FRANKLIN RESOURCES INC (5,230,877 shares), STATE STREET CORP (4,398,171 shares), and FMR LLC (3,346,791 shares).
This table shows the top 214 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.